Product custom-nanocomposites-nanopeptides

Home > products > custom-nanocomposites> nanopeptides

Catalog	name	Description	price
R-M1-8887	Fluvoxamine@LNP-TFR (sequence:THRPPMWSPVWP) 100nm	The Fluvoxamine@Liposome nanoparticles-TFR (sequence: THRPPMWSPVWP) involves the targeted delivery of the therapeutic drug fluvoxamine using liposome nanoparticles functionalized with a peptide sequence that targets transferrin receptors. This type of drug delivery system has the potential to enhance the specificity and efficiency of drug delivery to particular cells or tissues in the body.	price>
R-M2-9507	S2P(CRTLTVRKC)-PLGA-Maleimide-PEG2k nanoparticles containing Imatinib	S2P peptide-conjugated PLGA-Maleimide-PEG nanoparticles/S2P(CRTLTVRKC)-PLGA-Maleimide-PEG2k nanoparticles containing Imatinib containing Imatinib for targeting drug delivery to atherosclerotic plaques.Stabilin-2 peptide with sequence of CRTLTVRKC is a specific ligand to stabilin-2,so it was synthesized for using as the targeting agent for atherosclerosis.	price>
R-M2-9509	S2P Peptide-PLGA-Maleimide-PEG nanoparticles	S2P peptide-PLGA-Maleimide-PEG nanoparticles/CRTLTVRKC-PLGA-Maleimide-PEG nanoparticles/S2P Peptide(CRTLTVRKC)-PLGA-Maleimide-PEG nanoparticles is a promising approach to targeted drug delivery. Targeting specific types of cancer cells using S2P peptides while delivering chemotherapeutics or RNA-based therapeutics.The system may be explored for delivering nucleic acids (DNA or RNA) for gene therapy applications, with the peptide aiding in cellular uptake.Utilizing this platform for delivering antigens or immune modulators to enhance immune response against tumors.	price>
R-M2-9510	CRTLTVRKC-PLGA-PEG nanoparticles containing imatinib	S2P Peptide-PLGA-PEG nanoparticles containing imatinib/S2P peptide (CRTLTVRKC) conjugated to PLGA-PEG nanoparticles is a sophisticated compound designed for improved delivery of imatinib. This approach aims to enhance the therapeutic efficacy of imatinib, a targeted treatment used primarily for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs), while minimizing side effects through more effective targeting and controlled release.The nanoparticles can be engineered to also deliver other chemotherapy agents or to administer alongside imatinib to create combination therapies that enhance anti-tumor efficacy.The S2P peptide facilitates targeting specific cancer cells, potentially improving the therapeutic index of imatinib by concentrating the drug where it is most needed.The PLGA matrix allows for controlled release, promoting a prolonged therapeutic effect and minimizing the peaks and troughs associated with traditional dosing regimens.By targeting cancer cells specifically, the risk of side effects associated with systemic drug exposure can be reduced.The PEGylation process enhances the solubility and stability of the nanoparticles, improving bioavailability.	price>
R-M2-9848	LyP-1-functionalized ENT-loaded nanoparticles	ENT-loaded LyP-1-functionalized nanosystem(LyP-1-PEG2k-NH2-CHT50k-PEI25k)/LyP-1-functionalized ENT-loaded nanoparticles/ENT-loaded LyP-1-modified nanoparticles/ENT-loaded LyP-1-functionalized nanosystem(LyP-1-PEG2k-NH2-Chitosan50k-PEI25k) from kamulinbio. Both TEM and SEM micrographs showed that spherical ENT-loaded LyP-1-modified nanoparticles were synthesized with an average particle size ranging between 30 and 200 nm (Figure a,b)	price>
R-M1-8303	cRGD-liposomes @temozolomide and erastin	cRGD-liposomes @temozolomide and erastin,Polypeptide cRGD modified liposomes coated with Temozolomide and erastin from kamulin.	price>
R-M2-9962	CaP@PHT-PEG2k-TAT nanoformulation	Calcium phosphate@Phenytoin-PEG2k-TAT nanoformulation/Calcium phosphate@Phenytoin-PEG-TAT(YGRKKRRQRRR) nanoformulation is a hybrid nanosystem composed of a calcium phosphate (CaP) nanocore encapsulating the antiepileptic drug phenytoin, and surface-modified with poly(ethylene glycol) (PEG) and the TAT peptide (YGRKKRRQRRR). Applications: Targeted and intracellular drug delivery of phenytoin for neurological or regenerative therapies; Enhanced cellular uptake via TAT-mediated translocation; Controlled, pH-triggered release of phenytoin in acidic environments (e.g., endosomes); Potential neuroprotective and anti-inflammatory applications in central nervous system disorders.	price>
R-M2-10013	Tannic acid manganese@serine nanoparticles	Tannic acid manganese@serine Nanoparticles/Tannic acid+manganese nanoparticles serine nanoparticles are a type of nanoparticle material. In biomedical materials, manganese ions are often used to construct nano contrast agents with magnetic resonance imaging (MRI) capabilities. Serine is a non essential amino acid that may serve as a stabilizer or functional modifier for nanoparticles to improve their biocompatibility or targeting. Tannic acid manganese@serine The potential applications of nanoparticles may include biomedical imaging (such as MRI contrast agents) or targeted therapy (such as anti-tumor drug delivery).	price>
R-M1-8386	Gold nanoparticles (15nm)-GSH	Glutathione (GSH) is a water-soluble tripeptide that is contained in biological fluids (blood, cell fluid) and plays an important role in the redox process of human and animal organisms. Gold nanoparticles modified graphite electrodes have electrocatalytic activity for the oxidation of glutathione in alkaline media.	price>
R-M1-8387	Gold nanoparticles (15nm)-Cys	Gold nanoparticles (15nm)-Cys,Gold nanoparticles (AuNPs)-cysteine (C) It can be used for research in fields such as targeted delivery and biological imaging. It can be customized into Gold nanoparticles (AuNPs) wrapped in different sizes of cysteine (C). Gold nanoparticles (AuNPs) have their high stability, biocompatibility and functionality.	price>

...